Good Friends
879 FISHERMAN STREET OPA LOCKA BLVD, OPA LOCKA, FL, 33054, United States
Overview
Good Friends help founders develop strong foundations for their businesses. Good Friends is a venture capital firm that was started in 2019 by the founders of Warby Parker, Harry's, and Allbirds. Good Friends invests in early-stage businesses with a consumer lens.
- Total investments
- 38
- Lead investments
- 2
- Investments · 12mo
- 2
- Active investors
- 0
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Climatic
Participated · Seed · Feb 2026
Climatic is building a new consumer category around proactive, everyday lung care. Grounded in more than three years of research led by Chief Science Officer Dr. Dale Christensen of Duke University Medical Center, the company’s first product is L Max, a daily lung health system slated to launch in late spring 2026. In pre-clinical studies, a single dose of L Max improved mucus clearance by over 50% within minutes, with effects lasting eight hours, and the result has been replicated in more than ten independent tests. A five-week user study with endurance athletes showed 98% reporting easier breathing and an average 6% improvement in time trials, while 80% saw better heart-rate variability; a larger randomized, placebo-controlled clinical trial is underway. Co-founded by CEO Eric Kau (former Seed Health COO) and CCO Allie Melnick (former Harry’s executive), Climatic has assembled advisors from Mayo Clinic, elite athletics, and leading consumer brands. The company plans to expand its portfolio into additional products addressing environmental health stressors. Climatic’s $10 million seed financing provides the capital to accelerate research, grow the team, and prepare for product launch.
- Biologica
Participated · Seed · Dec 2025
Biologica is a San Francisco–based women’s health company offering a line of effervescent, sugar-free daily supplements formulated for distinct hormonal phases: Primary Essentials for the reproductive years, Midlife Essentials for perimenopause, and Postmenopause Essentials for life after menopause. Each product combines clinically studied ingredients—such as targeted probiotic strains, vitamin B-complex, and electrolytes—at research-backed dosages to address symptoms ranging from mood and PMS to brain fog and bone strength. The formulas were developed with input from an expert medical advisory board of OB/GYNs, a breast-cancer surgeon, and naturopathic doctors, and informed by a 1,000-woman health study. Products retail for $70 per tin, with a $59 monthly subscription option sold directly through biologica.com. Co-founded by Liz Zwillinger and Allbirds co-founder Joey Zwillinger, the company emphasizes recyclable packaging featuring Greco-Roman–inspired relief artwork. Biologica has raised $7 million in seed financing to support product launch and further development. The fresh capital positions the startup to scale manufacturing, expand distribution, and deepen research into additional stage-specific formulations.
- Drivepoint
Participated · Series A · Aug 2025
Drivepoint provides an AI-native strategic finance platform built for consumer and retail brands, combining spreadsheet-native flexibility with deep retail integrations and forecasting tools. The product enables finance teams to model, plan, and make decisions in real time without rebuilding workflows. Customers cited include Curology, True Classic, Simple Modern, Graza, Oats Overnight, and Dose, with reported outcomes such as average 6.7% gains in EBITDA in the first year, $4M of unlocked EBITDA for Oats Overnight, and 3–5% gross-margin improvement for Dose. Drivepoint emphasizes scenario planning, variance analysis, and decision intelligence to drive inventory and marketing efficiency. The company plans to use the new capital to double down on AI product development and scale go-to-market efforts toward mid-market and enterprise brands. Drivepoint is based in Boston and positions itself as the default solution for intelligent finance in retail.
- OneText
Participated · Seed · Jul 2025
OneText builds a text-to-buy commerce platform that lets shoppers complete purchases by SMS without replacing a merchant’s existing checkout. The product pairs AI-powered two-way conversations with human-in-the-loop support to drive features like cart recovery, post-purchase upsells, and shopper-specific recommendations. Under the hood OneText runs its own wallet that integrates with a brand’s payment processor and securely vaults customer payment information for one-reply reorders using a card-on-file model and “consentful” automation. The company positions itself against mass SMS marketing by focusing on personalized, conversion-oriented interactions and reports improving conversions by 20–30%. OneText serves mid-sized e-commerce brands doing $10M–$100M in annual revenue, supports smaller startups and large enterprises, and says it has been scaling 3x year-over-year and doing millions in revenue. Over time it plans to expand the vaulted-profile network so shoppers can reuse pre-filled checkout data and recommendations across multiple brands, building toward a cross-brand, SMS-native payment network.
- Air Inc.
Participated · Series B · Jan 2025
Air provides a purpose-built platform that streamlines creative workflows, allowing teams to gather, approve, and distribute visual content more efficiently. The software is currently used by over 100,000 creatives at more than 2,100 businesses, who together manage in excess of 120 million digital assets on the platform. By automating time-consuming tasks, Air aims to free creative professionals to focus on higher-value work. The company plans to use its newly raised capital to further its mission of automating workflows for creative teams worldwide, suggesting continued investment in product development and market expansion. Since launch, Air has attracted backing from prominent venture firms such as Tiger Global, Headline Ventures, Lerer Hippeau, WndrCo, Slack Ventures, Designer Fund, and Good Friends. Including the recent Series B, its total funding now exceeds $70 million, underlining strong investor confidence in the firm’s growth trajectory and market opportunity.
Team
No current team members are available.